(1R,1'R,4R,4'R)-4,4'-(1,4-phenylenebis(methylene))bis(1-(hydroxymethyl)-5,7-dimethyl-2,3-dithia-5,7-diazabicyclo[2.2.2]octane-6,8-dione)

ID: ALA4555191

Chembl Id: CHEMBL4555191

PubChem CID: 132037266

Max Phase: Preclinical

Molecular Formula: C22H26N4O6S4

Molecular Weight: 570.74

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)[C@@]2(Cc3ccc(C[C@]45SS[C@](CO)(C(=O)N4C)N(C)C5=O)cc3)SS[C@]1(CO)C(=O)N2C

Standard InChI:  InChI=1S/C22H26N4O6S4/c1-23-17(31)21(11-27)25(3)15(29)19(23,33-35-21)9-13-5-7-14(8-6-13)10-20-16(30)26(4)22(12-28,36-34-20)18(32)24(20)2/h5-8,27-28H,9-12H2,1-4H3/t19-,20-,21-,22-/m1/s1

Standard InChI Key:  WGLWNZBIJQLQOG-GXRSIYKFSA-N

Alternative Forms

  1. Parent:

    ALA4555191

    ---

Associated Targets(Human)

EP300 Tchem Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EP300 Tchem Histone acetyltransferase p300 (1259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 570.74Molecular Weight (Monoisotopic): 570.0735AlogP: 0.19#Rotatable Bonds: 6
Polar Surface Area: 121.70Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.79CX Basic pKa: CX LogP: 1.85CX LogD: 1.85
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.46Np Likeness Score: 0.77

References

1. Li J, Xi W, Li X, Sun H, Li Y..  (2019)  Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.,  27  (7): [PMID:30819620] [10.1016/j.bmc.2019.01.042]

Source